Healthtech Investors & VC Firms in Europe
1567 firms in this list, with a median first check of $500K. 434 of them lead rounds. Generated from verified public data and updated continuously.
DRI Healthcare
Toronto
42 people
Capital Q® Ventures Inc.
MaitlandSeed–Growth
26 people
SixThirty Ventures
St. LouisPre-Seed–Growth$100K – $250K
14 people
KDDI Open Innovation Fund
Seed–Growth
1 person
TRAC (Third Round Analytics Capital)
San FranciscoSeed–Series B$250K – $2M
9 people
SR One Capital Management
Redwood CitySeed–Series B
31 people
Platinum
Beverly HillsGrowth–Late Stage$100M – $10B
30 people
Columbia Pacific Advisors
SeattleSeries A–Series B
51 people
Sterling Road
San FranciscoPre-Seed–Seed$25K – $150K
11 people
LifeX Ventures
San FranciscoPre-Seed–Series A
22 people
Relay Investments
Boston$1M – $3.5M
25 people
Wesley Clover International Corporation
OttawaSeed–Growth
36 people
Ventech China
ShanghaiPre-Seed–Series B
21 people
Leeds
New YorkGrowth$40M
36 people
Leo Capital Ventures
SingaporePre-Seed–Seed
20 people
MassMutual Ventures
SpringfieldSeed–Series B$500K – $5M
13 people
OMERS Ventures
TorontoPre-Seed–Series C$5M – $25M
15 people
Energy & Environment Investment
TokyoSeed–Series B
18 people
Supermoon Capital
San FranciscoPre-Seed–Series A$150K – $2.5M
36 people
IGNIA
Mexico CitySeed–Series A$100K – $5M
20 people
Bain Capital Tech Opportunities
BostonGrowth
36 people
Mission Biocapital
San FranciscoPre-Seed–Series A$500K
21 people
ACME Capital
San FranciscoPre-Seed–Growth
13 people
Nimble Partners
San FranciscoSeed–Late Stage
11 people
Related lists
Investors & VC Firms in North America (13326)Investors & VC Firms in United States (12318)Investors & VC Firms in Europe (6083)AI & Machine Learning Investors & VC Firms (5352)Investors & VC Firms in Global (5318)Fintech Investors & VC Firms (5140)Healthtech Investors & VC Firms (4657)SaaS Investors & VC Firms (4528)Enterprise Software Investors & VC Firms (4424)Crypto & Web3 Investors & VC Firms (4140)
Data sourced from public filings and firms' own websites — see our methodology.






































































































